Author

I. V. Balyasnikova

Primary ORCID profile (0000-0002-4664-9441 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

I. V. BalyasnikovaiD1 paper · Northwestern University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:imaging· 1

Frequent Co-Authors

C. D. James· 2 shared C. Horbinski· 2 shared D. Procissi· 2 shared K. C. Pituch· 2 shared L. Ilut· 2 shared M. Chastkofsky· 2 shared M. S. Lesniak· 2 shared M. Zannikou· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. D. James

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivApr 19, 2022

Low Level Whole-Brain Radiation Enhances Theranostic Potential Of Single Domain Antibody Fragments For HER2-Positive Brain Metastases

D. Procissi, S. Jannetti, M. Zannikou…·I. V. Balyasnikova

This study shows that low-dose whole-brain irradiation increases the uptake of an anti-HER2 VHH in intracranial tumors, enhancing its theranostic potential for HER2-positive brain metastases.

DOI 10.1093/noajnl/vdac135

𝕏 PostBluesky

ImmunologybioRxivJul 21, 2020

Neural Stem Cells Secreting Bispecific T Cell Engager to Induce Selective Anti-Glioma Activity

K. C. Pituch, M. Zannikou, L. Ilut…·I. V. Balyasnikova

This study develops neural stem cells secreting a bispecific T cell engager (BiTE) to target glioblastoma, showing survival benefits in mice with IL13R2+ tumors.

DOI 10.1073/pnas.2015800118

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivMay 9, 2020

MSCs Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

M. Chastkofsky, K. C. Pituch, H. Katagi…·I. V. Balyasnikova

This study shows that mesenchymal stem cells can deliver oncolytic virotherapy to DIPG tumors, significantly improving survival when combined with radiotherapy in preclinical models.

DOI 10.1158/1078-0432.ccr-20-1499

mouseexperimental assay

𝕏 PostBluesky